Cargando…
Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?
Anti-arrhythmic drugs are a mainstay in the management of symptoms related to arrhythmias, and are adjuncts in prevention and treatment of life-threatening ventricular arrhythmias. However, they also have the potential for pro-arrhythmia and thus the prediction of arrhythmia predisposition and drug...
Autores principales: | Lane, Jem D., Tinker, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681497/ https://www.ncbi.nlm.nih.gov/pubmed/29163223 http://dx.doi.org/10.3389/fphys.2017.00890 |
Ejemplares similares
-
Fatigue in Aviation: Safety Risks, Preventive Strategies and Pharmacological Interventions
por: Wingelaar-Jagt, Yara Q., et al.
Publicado: (2021) -
Editorial: Safety Pharmacology – Risk Assessment QT Interval Prolongation and Beyond
por: Grandi, Eleonora, et al.
Publicado: (2018) -
Virtual Lobule Models Are the Key for Multiscale Biomechanical and Pharmacological Modeling for the Liver
por: Ho, Harvey, et al.
Publicado: (2020) -
Tissue-Level Cardiac Electrophysiology Studied in Murine Myocardium Using a Microelectrode Array: Autonomic and Thermal Modulation
por: Lane, Jem D., et al.
Publicado: (2017) -
Is There Any Practical Application of Meta-Analytical Results in Strength Training?
por: Gentil, Paulo, et al.
Publicado: (2017)